Abbott Laboratories (ABT) Cash from Discontinued Operations (2015 - 2016)

Abbott Laboratories' (ABT) quarterly Cash from Discontinued Operations came in at 25000000.0 in Q1 2016, down 99.11% year-on-year from 2821000000.0 in Q2 2015, and up 733.33% quarter-over-quarter from 3000000.0 in Q4 2015.

Abbott Laboratories (ABT) Cash from Discontinued Operations (2015 - 2016) Analysis & Trends

Abbott Laboratories has disclosed Cash from Discontinued Operations across 2 years of filings, most recently posting 25000000.0 for Q1 2016.

  • Cash from Discontinued Operations for Q1 2016 came in at 25000000.0, down 99.11% year-over-year; the trailing twelve-month figure through Dec 2016 was 25000000.0 (down 99.12% YoY), and the FY2016 annual result was 25000000.0, down 99.12% from the prior year.
  • Cash from Discontinued Operations came in at 25000000.0 for Q1 2016 at Abbott Laboratories, up from 3000000.0 in the prior quarter.
  • In the past five years, Cash from Discontinued Operations ranged from a high of 2821000000.0 in Q1 2015 to a low of 1000000.0 in Q2 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2016 25.00 Mn
Mar 31, 2016 25.00 Mn
Dec 31, 2015 3.00 Mn
Dec 31, 2015 3.00 Mn
Sep 30, 2015 17.00 Mn
Sep 30, 2015 17.00 Mn
Jun 30, 2015 -1.00 Mn
Jun 30, 2015 -1.00 Mn
Mar 31, 2015 2.82 Bn
Mar 31, 2015 2.82 Bn